Mercado mundial del trastorno por acumulación: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado del trastorno de acumulación

El trastorno de acaparamiento se produce cuando una persona acumula una cantidad excesiva de objetos y los mantiene de forma desorganizada, lo que da lugar a un desorden inmanejable. Es posible que los objetos tengan poco o ningún valor monetario. Los trastornos de acaparamiento son difíciles de curar porque muchos acaparadores no son conscientes de que tienen un problema o no son conscientes de cómo afecta a sus vidas o a las de los demás. Este trastorno neurológico se caracteriza por vivir en espacios inutilizables debido al desorden, la incapacidad de deshacerse de las posesiones, la ansiedad por necesitar objetos en el futuro, el estrés extremo por tirar objetos, la desconfianza de que los demás toquen las posesiones, la incertidumbre sobre dónde poner las cosas, el alejamiento de amigos y familiares, entre otros.

Data Bridge Market Research analiza que el mercado del trastorno de acumulación se valoró en USD 978,98 millones en 2022 y se espera que alcance el valor de USD 1.381,58 millones para el año 2030, a una CAGR del 4,40% durante el período de pronóstico. Esto indica que el valor de mercado. La “terapia cognitivo-conductual (TCC)” domina el segmento de tratamiento del mercado del trastorno de acumulación debido a la creciente prevalencia de arritmias cardíacas. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado del trastorno de acumulación

Market Definition

Hoarding disorder market refers to the market for products, therapies, and services aimed at addressing the symptoms and challenges associated with hoarding disorder. It includes medications, counseling, professional organizing services, and other interventions designed to assist individuals in managing and reducing hoarding behaviors.

Global Hoarding Disorder Market Dynamics

Drivers

• Increased Awareness and Understanding of Hoarding Disorder

Growing awareness among the general public, healthcare professionals, and mental health organizations about hoarding disorder contributes to increased recognition and diagnosis of the condition, driving the demand for appropriate interventions.

• Rising Prevalence of the Disorder

Hoarding disorder is being increasingly recognized as a distinct mental health condition, with prevalence rates estimated to be higher than previously thought. The rising prevalence fuels the demand for interventions and treatment options.

• Advancements in Therapeutic Approaches

Ongoing research and advancements in therapeutic approaches, such as cognitive-behavioral therapy (CBT), motivational interviewing, and harm reduction strategies, offer promising options for the treatment of hoarding disorder, stimulating market growth.  

Opportunities

The government initiatives, schemes, or funding that support and promotes the innovation and development of the Hoarding Disorder market provide growth opportunities for the market players in the forecast period of 2023 to 2030. Additionally, the Development of Innovative and Personalized Treatment approaches, collaborations between healthcare professionals and mental health organizations, penetration rate, market expansion in developing countries, and increasing per capita expenditure on healthcare will further expand the market's growth rate in the future. 

Restraints

Limited Access to Specialized Care

Access to specialized care for hoarding disorder, including mental health professionals with expertise in hoarding behavior, may be limited in certain regions or healthcare systems. This can hinder timely and appropriate treatment.

Challenges

Lack of Standardized Diagnostic Criteria and Treatment Guidelines

The absence of universally accepted diagnostic criteria and treatment guidelines for hoarding disorder can lead to variations in diagnosis and treatment approaches, posing challenges in ensuring consistent and effective care. Also, co-occurring mental health conditions, challenges in engaging and sustaining individuals in treatment, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.

This hoarding disorder market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Hoarding Disorder market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In June 2023, The Recovery Village estimated that hoarding affects 1 in every 50 people, but it may impact as many as 1 in every 20. According to the National Alliance on Mental Illness (NAMI), Massachusetts, up to 5 percent of the world’s population displays symptoms of clinically-diagnosable hoarding.

Global Hoarding Disorder Market Scope

The hoarding disorder market is segmented on the basis of treatment, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Cognitive-Behavioral Therapy (CBT)
• Antidepressants
• Others

Symptoms

• Living in unusable spaces due to clutter
• Inability to get rid of possessions
• Anxiety about needing items in the future
• Extreme stress about throwing out items
• Distrust of others touching possessions
• Uncertainty about where to put things
• Withdrawing from friends and family
• Others

Dosage

• Tablet
• Injection
• Others

Route of Administration

• Oral
• Intravenous
• Others

End-Users

• Clinic
• Hospital
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Hoarding Disorder Market Regional Analysis/Insights

The hoarding disorder market is analysed, and market size insights and trends are provided by country, treatment, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the hoarding disorder market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the hoarding disorder market due to the presence of major key players, high healthcare expenditure and well-developed healthcare infrastructure in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Crecimiento de la base instalada de infraestructura sanitaria y penetración de nuevas tecnologías

El mercado del trastorno de acaparamiento también le proporciona un análisis detallado del mercado para el crecimiento de cada país en el gasto de atención médica para equipos de capital, la base instalada de diferentes tipos de productos para el mercado del trastorno de acaparamiento, el impacto de la tecnología que utiliza curvas de línea de vida y los cambios en los escenarios regulatorios de la atención médica y su impacto en el mercado del trastorno de acaparamiento. Los datos están disponibles para el período histórico 2010-2020.

Análisis del panorama competitivo y de la cuota de mercado global del trastorno de acaparamiento

El panorama competitivo del mercado del trastorno de acumulación proporciona detalles por competidores. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento del producto, la amplitud y la variedad del producto, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas relacionado con el mercado del trastorno de acumulación.

Algunos de los principales actores que operan en el mercado del trastorno de acumulación son:

• F. Hoffmann-La Roche Ltd. (Suiza)
• Mylan NV (Estados Unidos)
• Industrias farmacéuticas Teva Ltd. (Israel)
• Sanofi (Francia),
• Pfizer Inc. (Estados Unidos)
• GlaxoSmithKline plc (Reino Unido)
• Novartis AG (Suiza)
• AstraZeneca (Reino Unido)
• Johnson & Johnson (Estados Unidos)
• Bayer AG (Alemania)
• Industrias farmacéuticas Sun Ltd. (India)
• Eli Lilly and Company (Estados Unidos)
• Edenbridge Pharmaceuticals, LLC (Estados Unidos)
• ParaPRO LLC (Estados Unidos)
• Ética de Encube (India)
• GALDERMA (Suiza)
• Alliance Pharmaceuticals (Reino Unido)
• Foamix Pharmaceuticals Ltd (Estados Unidos)
• Arbor Pharmaceuticals (Estados Unidos)
• Laboratorios Dr. Reddy Ltd. (India)
• Perrigo Company plc (Irlanda)

SKU-67030